In summary, in the glioma microenvironment, NLGN3 secreted by neurons and glioma cells activates LYN and upregulates ADAM10 expression, which can cleave NLGN3 to promote its secretion (Figure 6). The gene discussed is ADAM10; the disease is central nervous system cancer.